AN2 Therapeutics Inc. (ANTX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-10
4:57 pm
Purchase
2022-12-3113GAN2 THERAPEUTICS INC
ANTX
Adjuvant Global Health Technology Fund, L.P.2,597,380
13.400%
2,597,380increase
(New Position)
Filing
History
2022-04-08
4:31 pm
Purchase
2022-03-2913GAN2 THERAPEUTICS INC
ANTX
RA Capital Management, L.P.3,666,663
19.600%
3,666,663increase
(New Position)
Filing
History
2022-04-08
4:11 pm
Purchase
2022-03-2913GAN2 THERAPEUTICS INC
ANTX
Citadel Advisors LLC1,337,017
7.100%
1,337,017increase
(New Position)
Filing
History
2022-04-04
4:38 pm
Purchase
2022-03-2513GAN2 THERAPEUTICS INC
ANTX
BIOTECHNOLOGY VALUE FUND L P1,616,665
8.600%
1,616,665increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2